As of the latest SEC filings, Biohaven Ltd. (BHVN) is held by 179 institutional funds. The largest fund shareholder is State Street(R) SPDR(R) S&P(R) Biotech ETF (XBI), holding an estimated $32,526,009.72 in market value, representing 0.44% of its portfolio.
Funds holding Biohaven Ltd. (BHVN)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BHVN
- CIK:
- 0001935979
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 0.44% | $32,526,009.72 | 3,844,682 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.03% | $24,156,912.42 | 2,855,427 | Mar 31, 2026 | May 28, 2026 |
|
JAGLX
Janus Henderson Global Life Sciences Fund
|
MF | Independent / Boutique | 0.36% | $18,783,213.48 | 2,220,238 | Mar 31, 2026 | May 29, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.35% | $18,467,665.92 | 1,603,096 | Feb 28, 2026 | Apr 24, 2026 |
|
JATTX
Janus Henderson Triton Fund
|
MF | Independent / Boutique | 0.29% | $14,932,323.00 | 1,765,050 | Mar 31, 2026 | May 29, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.03% | $11,146,869.37 | 1,162,343 | Apr 30, 2026 | Jun 26, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $10,736,932.86 | 1,269,141 | Mar 31, 2026 | May 28, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.10% | $10,393,566.84 | 1,228,554 | Mar 31, 2026 | May 28, 2026 |
|
SMCWX
SMALLCAP World Fund Inc
|
MF | Independent / Boutique | 0.01% | $9,882,760.50 | 1,168,175 | Mar 31, 2026 | May 28, 2026 |
|
JAVTX
Janus Henderson Venture Fund
|
MF | Independent / Boutique | 0.28% | $8,716,270.32 | 1,030,292 | Mar 31, 2026 | May 29, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.07% | $8,118,021.42 | 959,577 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.10% | $7,762,346.10 | 917,535 | Mar 31, 2026 | May 28, 2026 |
|
PINK
Simplify Health Care ETF
|
ETF | Independent / Boutique | 3.28% | $7,683,075.90 | 908,165 | Mar 31, 2026 | May 27, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.02% | $6,896,344.32 | 598,641 | Feb 28, 2026 | Apr 24, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 1.16% | $6,526,483.92 | 771,452 | Mar 31, 2026 | May 29, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.03% | $6,437,318.40 | 558,795 | Feb 28, 2026 | Apr 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.04% | $5,352,053.76 | 464,588 | Feb 28, 2026 | Apr 28, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.02% | $4,659,713.87 | 485,893 | Apr 30, 2026 | Jun 26, 2026 |
|
VSEQX
VANGUARD STRATEGIC EQUITY FUND
|
MF | Vanguard | 0.04% | $4,150,467.54 | 490,599 | Mar 31, 2026 | May 28, 2026 |
|
VHCIX
VANGUARD HEALTH CARE INDEX FUND
|
ETF | Vanguard | 0.02% | $4,032,668.16 | 350,058 | Feb 28, 2026 | Apr 28, 2026 |
|
SHSKX
BlackRock Health Sciences Opportunities Portfolio
|
MF | BlackRock / iShares | 0.06% | $4,018,544.64 | 348,832 | Feb 27, 2026 | Apr 24, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.03% | $2,716,675.20 | 321,120 | Mar 31, 2026 | May 28, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.03% | $2,476,895.61 | 258,279 | Apr 30, 2026 | Jun 25, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $2,431,065.60 | 211,030 | Feb 28, 2026 | Apr 24, 2026 |
|
BDSKX
BlackRock Advantage Small Cap Core Fund
|
MF | BlackRock / iShares | 0.05% | $2,248,012.80 | 195,140 | Feb 27, 2026 | Apr 24, 2026 |
Advertisement (320x50)